Kramer Capital Partners
VC Fund
Stamford, United States
Kramer Capital Partners is a venture capital company based in Stamford, Connecticut.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kramer Capital Partners invests in
Stages Kramer Capital Partners invests in
Countries Kramer Capital Partners invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Health Diagnostics 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $30M / Series C / Dec 03, 2012 | |
|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M / Series B / Jan 22, 2008 | |
|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M / Series A / Jan 01, 2006 |
Co-Investors
LaunchCyte
3 deals together
Saturn Partners
3 deals together
Biogen
1 deal together
Innovation Works
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Kramer Capital Partners invest in?
Kramer Capital Partners invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kramer Capital Partners last invest?
The most recent investment recorded for Kramer Capital Partners closed in Dec 2012. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
